Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- PTNS-MIndependent statistical analysis of Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PTP-NPIndependent statistical analysis of Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02979925).
- PTSCIndependent statistical analysis of Persistence-Targeted Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654107).
- PTSC-SIndependent statistical analysis of Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873337).
- PTSDIndependent statistical analysis of Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574974).
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide: Complete Statistical AnalysisIndependent statistical analysis of Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pulmonary Function After Hyperbaric Oxygen Therapy: Complete Statistical AnalysisIndependent statistical analysis of Pulmonary Function After Hyperbaric Oxygen Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05088772).
- PULSIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PULSARIndependent statistical analysis of A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PULSED AFIndependent statistical analysis of Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04198701).
- Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PUMPIndependent statistical analysis of Prometra's Utilization in Mitigating Pain (PUMP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00817596).
- PUMP-ExIndependent statistical analysis of Exercise-primed Upper Extremity Motor Practice in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04259424).
- Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PUPs B-LONGIndependent statistical analysis of Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PuraBond PROOFIndependent statistical analysis of PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PURPOSEIndependent statistical analysis of Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PUSHIndependent statistical analysis of Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063880).
- PVPIndependent statistical analysis of A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- PyreneesIndependent statistical analysis of Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: Complete Statistical AnalysisIndependent statistical analysis of Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.: Complete Statistical AnalysisIndependent statistical analysis of QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- QP ExCELsIndependent statistical analysis of Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QuadIndependent statistical analysis of Comparison of Skin Substitutes Used in Burn Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676013).
- Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03408483).
- QUALIFY IPFIndependent statistical analysis of Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Qualitative Assessment of Implementing Routine Rapid HIV Testing: Complete Statistical AnalysisIndependent statistical analysis of Qualitative Assessment of Implementing Routine Rapid HIV Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680862).
- Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): Complete Statistical AnalysisIndependent statistical analysis of Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- QUANTIFYIndependent statistical analysis of The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845130).
- Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- QUARTO_IIIIndependent statistical analysis of Quartet Lead and Resynchronization Therapy Options III (QUARTO_III): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02476201).
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QuickOpt Chronic Study: Complete Statistical AnalysisIndependent statistical analysis of QuickOpt Chronic Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01172067).
- QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02383498).
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- QUINCEIndependent statistical analysis of Ophthalmic Compatibility During Seven Days of Continuous Wear of Silicone Hydrogel Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- QUITIndependent statistical analysis of A Pilot Randomized Controlled Trial of Financial Incentives, Text Messaging, and Usual Care for Homeless Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Quit or Switch: E-cigarette Study: Complete Statistical AnalysisIndependent statistical analysis of Quit or Switch: E-cigarette Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05525078).
- QUORUMIndependent statistical analysis of Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- R-CHOPIndependent statistical analysis of Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…